Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kidney Cancer Stage Iv”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00014274
What this trial is testing

Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 238
Testing effectiveness (Phase 2)Ended earlyNCT00324740
What this trial is testing

Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Recurrent Renal Cell CancerStage III Renal Cell CancerStage IV Renal Cell Cancer
National Cancer Institute (NCI) 14
Early research (Phase 1)Active Not RecruitingNCT05122546
What this trial is testing

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Papillary Renal Cell CarcinomaAdvanced Renal Cell Carcinoma+9 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT00096525
What this trial is testing

Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00053820
What this trial is testing

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Medical Research Council 670
Not applicableEnded earlyNCT00899860
What this trial is testing

Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer

Who this might be right for
Kidney Cancer
Wake Forest University Health Sciences 30
Testing effectiveness (Phase 2)Study completedNCT01089088
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 63
Large-scale testing (Phase 3)Looking for participantsNCT06364631
What this trial is testing

CARE1 Pragmatic Clinical Trial

Who this might be right for
Metastatic Kidney CancerMetastatic Kidney Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 1,250
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00019396
What this trial is testing

Flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer

Who this might be right for
Stage IV MelanomaStage IV Renal Cell CancerRecurrent Renal Cell Cancer+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT02298959
What this trial is testing

Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer

Who this might be right for
Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Colorectal CarcinomaMetastatic Malignant Solid Neoplasm+12 more
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)Study completedNCT00101114
What this trial is testing

Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more
National Cancer Institute (NCI) 55
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725
What this trial is testing

Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more
Fred Hutchinson Cancer Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03682289
What this trial is testing

Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Pancreatic CancerLocally Advanced Malignant Solid Neoplasm+10 more
Rahul Aggarwal 83
Early research (Phase 1)Active Not RecruitingNCT02496208
What this trial is testing

Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors

Who this might be right for
Bladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more
National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Study completedNCT00425386
What this trial is testing

Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
OHSU Knight Cancer Institute 60
Early research (Phase 1)Study completedNCT00659568
What this trial is testing

Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma

Who this might be right for
Breast CancerEndometrial CancerKidney Cancer+3 more
London Health Sciences Centre 28
Testing effectiveness (Phase 2)Study completedNCT01664182
What this trial is testing

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 41
Next Page